Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2001
05/30/2001EP0815106B1 3-aryluracils and intermediates for their preparation
05/30/2001EP0794184B1 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same
05/30/2001EP0641320B1 Substituted (s)-3-phenylpiperidine derivatives, their preparation and their use as dopamine autoreceptor antagonists
05/30/2001CN1297447A Anti-viral pyrimidine derivs
05/30/2001CN1297442A 5-aminoindeno [1,2-c] pyrazol-4-ones as anti-cancer and anti-proliferative agents
05/30/2001CN1297438A Substd. indolinones having inhibiting effect on kinases and cycline/CDK complexes
05/30/2001CN1297436A Substd. pyrrolidine hydroxamate metalloprotease inhibitors
05/30/2001CN1297350A Agents for relieving side effects
05/29/2001US6239306 Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulations
05/29/2001US6239287 Preparation of phosphonium compounds as intermediates for glycine antagonists
05/29/2001US6239282 Alkylating the corresponding 3-amidothiophene compound
05/29/2001US6239154 Arylacetamides, agonists at kappa opioid receptors.
05/29/2001US6239131 1,5 Benzodiazepine derivatives
05/29/2001US6239129 Characterised by an indole ring on the aromatic moiety by a cyano group and on the indole nitrogen by an aminoalkyl chain. great affinity for 5-ht2c receptors, useful for depression, panic attacks, obsessive-compulsive disorders, phobias,
05/29/2001US6239127 Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation
05/29/2001CA2325783A1 Ultraviolet-protecting cosmetic compounds containing amino- amidine derivatives and uses
05/25/2001WO2001036395A1 Triazoles as farnesyl transferase inhibitors
05/25/2001WO2000077027A3 Serine protease inhibitors
05/25/2001WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/24/2001US20010001799 Anticoagulant
05/23/2001EP1100786A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
05/23/2001EP1100779A1 Substituted indolinones, the production thereof and their use as medicaments
05/23/2001EP1100777A1 Sulfurated distamycin derivatives, process for preparing them, and their use as antitumor agents
05/23/2001EP1100519A1 Multibinding agents that modulate nmda receptors
05/23/2001EP1100506A1 Integrin receptor antagonists
05/23/2001EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders
05/23/2001EP0779887B1 Novel benzimidazole derivatives having cgmp-phosphodiesterase inhibiting activity
05/23/2001CN1296478A Histamine H3 receptor ligands
05/23/2001CN1296010A Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same
05/23/2001CN1066145C N-substituted 3-azabicyclo (3,2,0) heptane derivatives and preparing method and use thereof
05/23/2001CN1066142C 喹唑啉衍生物 Quinazoline derivatives
05/23/2001CN1066141C 3-(hetero)aryl carboxylic acid derivatives, methods of preparing them and intermediates used in their preparation
05/23/2001CN1066138C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones
05/23/2001CN1066137C Alpha-phenylbutenic acid methyl esters
05/22/2001US6235778 Anticoagulants
05/22/2001US6235768 Osteoporosis; rheumatic disorders; antitumor agents
05/22/2001US6235765 Benzimidazole derivatives
05/22/2001US6235760 Treatment for CNS injuries
05/22/2001US6235758 Indole derivatives as 5-HT receptor antagonist
05/22/2001US6235757 Substituted heterocycles
05/22/2001US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide
05/22/2001CA2217006C Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
05/17/2001WO2001034606A1 Pharmaceutically active isoindoline derivatives
05/17/2001WO2001034598A1 [(indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders
05/17/2001WO2001034597A1 N-aryl-(homopiperazinyl)-cyclohexyl amines as 5-ht transporters
05/17/2001WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
05/17/2001WO2001034585A1 Semicarbazone derivatives and their use as thrombopoietin mimetics
05/17/2001WO2001034578A1 Compounds with anti-helicobacter pylori activity
05/17/2001WO2001034576A2 Use of pyrimidinone derivatives for controlling undesired microorganisms
05/17/2001WO2001034573A1 Compounds
05/17/2001WO2001034572A2 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors
05/17/2001WO2001034567A1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa
05/17/2001WO2001034561A1 Processes for the preparation of sumatriptan and related compounds
05/17/2001WO2001034127A1 Prevention of plaque rupture by acat inhibitors
05/17/2001WO2001024796A8 1,2,4-triazole derivatives, composition, process of making and methods of use
05/17/2001DE19953899A1 Carboxamid-substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Carboxamide-substituted benzimidazole derivatives, processes for their preparation and their use as medicaments
05/17/2001CA2390531A1 ¬(indol-3-yl)-cycloalkyl|-3-substituted azetidines for the treatment of central nervous system disorders
05/17/2001CA2390530A1 N-aryl-(homopiperazinyl)-cyclohexyl amines as 5-ht transporters
05/17/2001CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
05/17/2001CA2389514A1 Processes for the preparation of sumatriptan and related compounds
05/17/2001CA2382676A1 Prevention of plaque rupture by acat inhibitors
05/16/2001EP1099692A1 N,n-substituted cyclic amine derivatives
05/16/2001EP1098892A1 Biphenyl derivatives
05/16/2001EP1098890A1 Dihydrotriazolone derivatives as pesticides
05/16/2001EP1098885A1 Imidazole compounds and their use as adenosine deaminase inhibitors
05/16/2001EP1098870A2 Nitric esters and nitrate salts of specific drugs
05/16/2001EP1098666A2 Water-soluble drugs and methods for their production
05/16/2001EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
05/16/2001EP1098644A1 Substituted benzimidazole antiviral agents
05/16/2001CN1295566A Trisubstituted 1,3,5-triazine derivatives for treatment by HIV infections
05/16/2001CN1295561A N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres
05/16/2001CN1295479A Beta 2-adrenergic receptor agonist
05/16/2001CN1294852A Use of pyridone derivatives in control of undesired microbe
05/15/2001US6232335 2,4-Dioxopyrrolidine and 2,4-dioxotetrahydrofan derivatives and medicines containing the same at the active ingredient
05/15/2001US6232334 Benzimidazole derivatives, their production and use
05/15/2001US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
05/15/2001US6232317 Bisimino-substituted phenyl compounds and their use as pesticides
05/15/2001US6232309 2-chloropyridine or 2-chlorothiazole derivatives of heterocyclic compounds used as pesticides
05/15/2001US6232307 2-phenyl-1-(4-(2-aminoethoxy)-benzyl)-indole compounds useful as estrogenic agents
05/15/2001CA2238978C Retroviral protease inhibiting compounds
05/10/2001WO2001033221A1 Axor35, a g-protein coupled receptor
05/10/2001WO2001032653A1 Heterocyclic substituted pyrazolones
05/10/2001WO2001032652A2 N-substituted carbamoyloxyalkyl-azolium derivatives
05/10/2001WO2001032649A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
05/10/2001WO2001032634A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
05/10/2001WO2001032633A1 Substituted 5-benzyl-2,4-diaminopyrimidines
05/10/2001WO2001032632A2 Pharmaceutically active 4-substituted pyrimidine derivatives
05/10/2001WO2001032628A1 Cyano compounds as factor xa inhibitors
05/10/2001WO2001032174A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists
05/10/2001WO2001032171A1 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline nmda/nr2b antagonists
05/10/2001CA2389807A1 Heterocyclic substituted pyrazolones
05/10/2001CA2389377A1 Substituted 5-benzyl-2,4-diaminopyrimidines
05/10/2001CA2389259A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists
05/10/2001CA2389234A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
05/10/2001CA2389184A1 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline nmda/nr2b antagonists
05/10/2001CA2387613A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them
05/09/2001EP1097932A1 Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest controllers and a method for using the same
05/09/2001EP1097927A1 Cyanoiminoquinoxaline derivatives
05/09/2001EP1097921A1 Phenylhydrazines
05/09/2001EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction